News
Italians ban Hib vaccine in BSE scare
BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7078.393j (Published 08 February 1997) Cite this as: BMJ 1997;314:393
- Kwame McKenzie
- Brussels
The Italian ministry of health has suspended the use and marketing of a vaccine against Haemophilus influenzae type b (Hib) because of fears that it could transmit bovine spongiform encephalopathy (BSE) to humans.
The police were called in to seize batches of HibTITER from the Italian outlets of the US manufacturer Wyeth-Lederle on 17 January. The vaccine was used in the Italian national vaccination programme, but the use of bovine heart-brain infusion agar to promote bacterial growth early in the manufacturing process has worried the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.